Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: Role of nitric oxide and bradykinin

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1261-1267

  Chen, Chien Ting ^a,c   Chu, Chi Jen ^a,c   Lee, Fa Yauh ^a,c   Chang, Full Young ^a,c   Wang, Sun Sang ^b,c   Lin, Han Chieh ^a,c   Hou, Ming Chih ^a,c   Wu, Shwu Ling ^b   Chan, Che Chang ^a,c   Huang, Hui Chun ^a,c   Lee, Shou Dong ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MUNICIPAL GAN DAU HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bradykinin; Common bile duct ligation; Glypressin; Hemorrhage; Hyposensitivity; Nitric oxide; Portal hypertension

Indexed keywords

BRADYKININ; CANAVANINE; ICATIBANT; ISOENZYME; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TERLIPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BLEEDING; COMMON BILE DUCT; CONTROLLED STUDY; DRUG INFUSION; LIVER CIRRHOSIS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW;

ANIMALS; BLOOD PRESSURE; BRADYKININ; CANAVANINE; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; HEART RATE; HYPERTENSION, PORTAL; LIGATION; LYPRESSIN; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PORTAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 71949094404     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodéz J. Measurements of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and hemodynamic correlation in 100 patients. J Hepatol 1985;1:125-139. (Pubitemid 15038042)
2. Conn HO. Vasopressin and nitroglycerin in the treatment of bleeding varices: the bottom line. Hepatology 1986;6:523-525.
3. Kravetz D, Cummings SA, Groszmann RJ. Hyposensitivity to vasopressin in a hemorrhage-transfused rat model of portal hypertension. Gastroenterology 1987;93:170-175. (Pubitemid 17084110)
4. Valla D, Girod C, Lee SS, Braillon A, Lebrec D. Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats. Hepatology 1988;8:10-15. (Pubitemid 18092051)
5. Tsai YT, Lee FY, Lin HC, Lee SD, Hsia HC, Lin WJ, Wang SS, Lay CS, Lai KH, Lo KJ. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage. Hepatology 1991;13:407-412.
6. Valla D, Geoffroy P, Girod C, Lebrec D. Circulatory actions of vasopressin in anesthetized rats with portal hypertension subjected to hemorrhage. J Hepatol 1986;2:328-339. (Pubitemid 16086596)
7. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-354.
8. Chu CJ, Lee FY, Wang SS, Chang FY, Lin HC, Hou MC, Wu SL, Tai CC, Chan CC, Lee SD. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension. Clin Sci 1998;95:629-636.
9. Paller MS, Linas SL. Role of angiogensin II, alpha-adrenergic system and arginine vasopressin on arterial pressure in the rat. Am J Physiol 1984;246:H25-30.
10. Haddy FT, Scott JB, Molnar JI. Mechanism of volume replacement and vascular constriction following hemorrhage. Am J Physiol 1965;208:169-181.
11. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992;16:1043-1048.
12. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide inhibition. Am J Physiol 1992;262:G996-1001.
13. Pizcueta P, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJ, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909-1915.
14. ω-nitro-L- arginine administration corrects peripheral vasodilation and systemic capillary hypotension, and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993;17:84-90. (Pubitemid 23027389)
15. Thiemermann C, Szab C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 1993;90:267-271. (Pubitemid 23010291)
16. Tesfamariam B, Cohen RA. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ Res 1988;63:720-725. (Pubitemid 18234628)
17. Rubanyi GM, Freay AD, Kauser K, Johns A, Harder DR. Mechanoreception by the endothelium: mediators and mechanisms of pressure- and flow-induced vascular responses. Blood vessels 1990;27:246-257. (Pubitemid 20365778)
18. Fleming I, Busse R. Tyrosine phosphorylation and bradykinin-induced signaling in endothelial cells. Am J Cardiol 1997;80:102-109A. (Pubitemid 27377482)
19. Fleming I, Hecker M, Busse R. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res 1994;74:1220-1226. (Pubitemid 24176917)
20. Gräfe M, Bossaller C, Graf K, Auch-Schwelk W, Baumgarten CR, Hildebrandt A, Fleck E. Effects of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol 1993;264:H1493-1497. (Pubitemid 23154136)
21. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
22. Laszlo F, Evans SM, Whittle BJR. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforme in rat intestinal microvasculature in vivo. Eur J Pharmacol 1995;272:169-175.
23. Griffiths MJD, Messent M, MacAllister RJ, Evans TW. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993;110:963-968. (Pubitemid 24005226)
24. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993;233:119-125.
25. Gayoto LC, Guzman J, Brito EM, Mies S, Pontieri V, Raia S, Silva Jr MR. Bradykinin release into portal blood during hemorrhagic shock. J Physiol 1979;292:80P-81P.
26. Miller VM, Vanhoutte PM. Endothelium-dependent responses and their potential relevance to the distribution of blood flow during haemorrhagic shock. Resuscitation 1989;18:165-171.
27. Chu CJ, Wu SL, Lee FY, Wang SS, Lin HC, Chan CC, Chang FY, Lee SD. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension: role of nitric oxide and bradykinin. Clin Sci 2000; 99:475-482 (Pubitemid 32014552)
28. Franco F, Gigou M, Szekely AM, Bismuth H. Portal hypertension after bile duct obstruction. Effect of bile diversion on portal pressure in the rat. Arch Surg 1979;114:1064-1067.
29. Atucha NM, Shah V, Garcia-Cardena G, Sessa WE, Groszmann RJ. Role of endothelium in the abnormal response to mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 1996;111:1627-1632. (Pubitemid 26404228)
30. Pilette C, Moreau R, Sogni P, Kirstetter P, Cailmail S, Pussard E, Lebrec D. Hemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension. Eur J Pharmacol 1996;312:63-68. (Pubitemid 26308957)
31. Teale DM, Atkinson AM. L-canavanine restores blood pressure in a rat model of endotoxic shock. Eur J Pharmacol 1994;271:87-92.
32. Liaudet L, Feihl F, Rosslet A, Markert M, Hurni M, Perret C. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxemia. Clin Sci 1996;90:369-377. (Pubitemid 26150162)
33. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke St, Breipohl G, Knolle J, et al. Hoe 140, a new potent and long acting bradykinin - antagonist: in vivo studies. Br J Pharmacol 1991;162:774-777.
34. Wu J, Akaike T, Maeda H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res 1998;58:159-165. (Pubitemid 28027731)
35. Wirth KJ. Bickel M. Hropot M. Gunzler V. Heitsch H. Ruppert D. Scholkens BA. The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCl4-induced liver cirrhosis: possible role of enhanced microvascular leakage. Eur J Pharmacol 1997;337:45-53 (Pubitemid 27468860)
36. Cameron GR, Hasan SM. Disturbances of structure and function in the liver as the result of biliary obstruction. J Pathol Bacteriol 1958;75:333-349.
37. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct ligation obstruction: a new experimental model of cirrhosis in the rat. Br J Exp Pathol 1984;65:305-311. (Pubitemid 14085298)
38. Lee FY, Chu CJ, Wang SS, Chang FY, Lin HC, Hou MC, Chan CC, Wu SL, Chen CT, Huang HC, Lee SD. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rats. Eur J Clin Invest 2001;31:145-153.
39. Marley R, Holt S, Fernando B, Harry D, Anand R, Goodier D, Davies S, Moore K. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 1999;29:1358-1363. (Pubitemid 29211034)
40. Pateron D, Oberti F, Lefilliatre P, Veal N, Tazi KA, Sogni P, Poirel O, Heller J, Moreau R, Cales P, Lebrec D. Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis. Clin Sci 1999;97:313-318. (Pubitemid 29425325)
41. Zimmermann H, Kurzen P, Klossner W, Renner EL, Marti U. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat. J Hepatol 1996;25:567-573. (Pubitemid 26345903)
42. Gadano AC, Sogni P, Yang S, Cailmail S, Moreau R, Nepveux P, Couturier D, et al. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. J Hepatol 1997;26:678-686. (Pubitemid 27112735)
43. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996;25:370-378. (Pubitemid 26323476)
44. Gadano AC, Sogni P, Heller J, Moreau R, Bories PN, Lebrec D. Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol 1999;30:896-903. (Pubitemid 29248992)
45. Fernández M, Garcia-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJR, Piqué JM, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 1995;108:1487-1495.
46. Tanoue K, Ohta M, Tarnawski AS, Wahlstrom KJ, Sugimachi K, Sarfeh IJ. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology 1996;110:549-557. (Pubitemid 26043889)
47. Criado M, Flores O, Ortiz MC, Hidalgo F, Rodriguez-Lopez AM, Eleno N, Atucha NM, Sanchez-Rodriguez A, Arevalo M, Garcia-Estan J, Lopez-Novoa JM. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation. Hepatology 1997;26:268-276.
48. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Mourelle M, Moncada S. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-1143 (Pubitemid 23320445)
49. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS, Lo KJ. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995;22:165-172
50. ω-nitro-L-arginine ameliorates portal systemic shunts in portal-hypertensive rats. Gastroenterology 1993;105:1464-1470. (Pubitemid 23315322)
51. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokines 1990;2:170-174.
52. Lamas A, Michel T, Brenner BM, Marsden PA. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-α. Am J Physiol 1991;261:C634-641.
53. Jacobsen ED, Berguer R, Higgins A, Stewart JM. Is bradykinin (BK) a physiological vasodilator in the gut? J Physiol Pharmacol 1993;44:323-332.
54. Boijsen E, Redman HC. Effect of bradykinin on celiac and superior mesenteric angiography. Invest Radiol 1966;1:422-430.
55. Lunderquist A, Tylen U, Norryd C. Portal pressure change after injection of bradykinin and vasopressin in celiac and superior mesenteric artery. Acta Chir Scand 1974;140:214-216.
56. Closa D, Hotter G, Prats N, Gelpi E, Rosallo-Catafau J. A bradykinin antagonist inhibited nitric oxide generation and thromoboxane biosynthesis in acute pancreatitis. Prostaglandins 1995;49:285-294.
57. Braun C, Ade M, Unger T, van der Woude FJ, Rohmeiss P. Effects of bradykinin and icatibant in renal hemodynamics in conscious spontaneously hypertensive and normotensive rats. J Cardiovasc Pharmacol 1997;30:446-454. (Pubitemid 27527579)
58. Paya D, Stoclet JC. Involvement of bradykinin and nitric oxide in the early hemodynamic effects of lipopolysaccharide in rats. Shock 1995;3:376-379.
59. Tropea MM, Gummelt D, Herzig MS, Leeb-Lunderberg LMF. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by Des-Arg9-bradykinin and bradykinin. J Pharmacol Exp Ther 1993;264:930-937.
60. Mombouli JV, Bissiriou I, Agboton V, Vanhoutte PM. Endothelium-derived hyperpolarizing factor; a key mediator of the vasodilator action of bradykinin. Immunopharmacology 1996;33:46-50. (Pubitemid 26247897)